Filter view on
Entry type
Status
Per-residue features
Colour by
Protein
GBC15499.1
Length
830 amino acids
Protein family membership
None predicted.
Domains and repeats
-
Domain4 - 101
- Aspartic peptidase domain (IPR021109)
220 - 399- Reverse transcriptase domain (IPR000477)
619 - 822
1
100
200
300
400
500
600
700
830
Detailed signature matches
no IPR
Unintegrated signatures
Residue annotation
-
Catalytic residue ...17D
-
catalytic motif cd...
-
inhibitor binding ...17D19G21A45C46T47I86I
-
Active site flap c...45C46T47I48A52K53I54A55A
-
putative NTP bindi...286D287L288A289A290G291F320F350D
-
putative active si...286Dputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)287Lputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)288Aputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)289Aputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)290Gputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)291Fputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)320Fputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)321Gputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)348Yputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)350Dputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)351Dputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)395Lputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR)396Gputative active site
286D, 287L, 288A, 289A, 290G, 291F, 320F, 321G, 348Y, 350D, 351D, 395L, 396G
CDD
cd01647 (RT_LTR) -
putative nucleic a...321G
-
active site cd09274
-
RNA/DNA hybrid bin...497DRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)498ARNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)499SRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)500GRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)534PRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)535IRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)536TRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)539ERNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)564DRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)597HRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)611RRNA/DNA hybrid binding site
497D, 498A, 499S, 500G, 534P, 535I, 536T, 539E, 564D, 597H, 611R
CDD
cd09274 (RNase_HI_RT_Ty3)
GO term prediction
Biological Process
GO:0006508 proteolysis
Molecular Function
GO:0004190 aspartic-type endopeptidase activity
Cellular Component
None predicted.